Remedi Unregistered Executive Heecheol Kim Reports 240 Share Holdings After New Listing, Negligible Market Impact

Heecheol Kim, unregistered executive and R&D director at Remedi, reported holdings of 240 shares acquired via new listing on July 13, 2026.
The 240 shares represent 0.00% of total outstanding shares of 7,625,791, causing zero dilution and no material price impact.
This is a routine insider ownership disclosure with no implications for management trading plans or corporate value changes.
[AI Summary]Remedi unregistered executive's trivial share acquisition disclosure confirms no capital structure change. Market impact nil, classified as non-material for investment decisions.